Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Rivaroxaban Granules

Approval Number

国药准字H20243387

Company江西施美药业股份有限公司

Registration Date

July 30, 2024

Drug Information

Generic Name

利伐沙班颗粒

Dosage Form

颗粒剂

Strength

15mg

Drug Type

化学药品

Registration Date

July 30, 2024

Company Information

Applicant Company

Company Name江西施美药业股份有限公司

Company Address

江西省抚州市东乡区大富工业园区

Manufacturing Company

Company Name江西施美药业股份有限公司

Company Address

江西省抚州市东乡区大富工业园区

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

利伐沙班颗粒 - NMPA 批准文号 | MedPath